MFS
SPRY icon

Mirabella Financial Services’s ARS Pharmaceuticals SPRY Stock Holding History

Mirabella Financial Services’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,117
Closed -$105K – 671
2024
Q1 		$105K Buy
+10,117
New +$75.4K 0.01% 474
2023
Q1 		– Sell
-10,573
Closed -$90.2K – 582
2022
Q4 		$90.2K Buy
+10,573
New +$68.6K 0.01% 347
2021
Q1 		– Sell
-11,340
Closed -$525K – 403
2020
Q4 		$525K Buy
+11,340
New +$379K 0.07% 166

Other funds holding SPRY

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirabella Financial Services's SPRY Position: Q2 2024 in Review

Mirabella Financial Services sold out of ARS Pharmaceuticals (SPRY) in Q2 2024, closing a stake of 10,117 shares — an estimated $105K sold.

Mirabella Financial Services first reported a position in SPRY in Q4 2020 and held it in 3 quarters. The position peaked at $525K in Q4 2020. 115 funds tracked by Wall St. Rank hold SPRY as of Q2 2024.

  • Mirabella Financial Services reported no remaining ARS Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Mirabella Financial Services sold 10,117 ARS Pharmaceuticals shares in Q2 2024, an estimated $105K.
  • Mirabella Financial Services first reported a position in ARS Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Mirabella Financial Services's ARS Pharmaceuticals position peaked at $525K in Q4 2020.
  • 115 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2024.

Based on Mirabella Financial Services's 13F filing for Q2 2024, filed 8 Aug 2024.